Bronchial Cough (Hyland’s)


Welcome to the PulseAid listing for the Bronchial Cough drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: POTASSIUM DICHROMATE,RUMEX CRISPUS ROOT and SANGUINARIA CANADENSIS ROOT
SUBSTANCE NAME: POTASSIUM DICHROMATE; RUMEX CRISPUS ROOT; SANGUINARIA CANADENSIS ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-01-21
END MARKETING DATE: 0000-00-00


Bronchial Cough HUMAN OTC DRUG Details:

Item DescriptionBronchial Cough from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2015-01-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-3222_5d0320c8-f765-7be4-e053-2a91aa0a1466
PRODUCT NDC: 54973-3222
APPLICATION NUMBER:

Other POTASSIUM DICHROMATE; RUMEX CRISPUS ROOT; SANGUINARIA CANADENSIS ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sBronchial Cough